Furthermore, the combination of these properties with enhanced tumorigenic and self-renewal capacity [10,13,15] suggests that SOX2+ cancer cells may contribute to disease progression, potentially having negative impacts on patient prognoses. This evidence concerns the gene SOX2 and cancer.